Specialists meeting your specialised needs

Medac statement regarding the coronavirus COVID-19:

At this moment in time, and after consultation of the competent authorities, we do not foresee any interruptions in production and therefore no supply shortages for our medicinal products because of the coronavirus COVID-19.

We support this by a prevention program and our purchasing and production strategy:

  • medac has prepared itself carefully to protect employees and supply chain,
  • medac operates its own production sites in Central Europe and the goods transport within Europe is not limited up to now,
  • generally, medac has more than one supplier for the intermediate products used for its medicinal products,
  • medac has sufficient stocks of all intermediate products so that supply fluctuations will not cause immediate shortages.

Utbildningsmaterial, checklista – Metotab

Den europeiska läkemedelsmyndighetens (EMA) säkerhetskommitté PRAC rekommenderar åtgärder för att förebygga doseringsfel med metotrexat.

Ladda ner utbildningsmaterial, checklista, för Metotab här.

Medacs produkter

Se våra registrerade produkter inom samtliga terapiområden.

Medacs produktansvariga

Hitta din närmaste produktansvarig.

Kontakta oss

Välkommen att kontakta oss.